ID   LOX12_RAT               Reviewed;         663 AA.
AC   F1LQ70;
DT   16-OCT-2013, integrated into UniProtKB/Swiss-Prot.
DT   03-MAY-2011, sequence version 1.
DT   29-MAY-2024, entry version 79.
DE   RecName: Full=Polyunsaturated fatty acid lipoxygenase ALOX12 {ECO:0000250|UniProtKB:P18054};
DE            EC=1.13.11.- {ECO:0000250|UniProtKB:P18054};
DE   AltName: Full=Arachidonate (12S)-lipoxygenase {ECO:0000305|PubMed:23382512};
DE            Short=12S-LOX;
DE            Short=12S-lipoxygenase {ECO:0000250|UniProtKB:P18054};
DE            EC=1.13.11.31 {ECO:0000269|PubMed:23382512};
DE   AltName: Full=Arachidonate (15S)-lipoxygenase {ECO:0000250|UniProtKB:P18054};
DE            EC=1.13.11.33 {ECO:0000250|UniProtKB:P18054};
DE   AltName: Full=Linoleate (13S)-lipoxygenase {ECO:0000250|UniProtKB:P39655};
DE   AltName: Full=Lipoxin synthase 12-LO;
DE            EC=3.3.2.-;
DE   AltName: Full=Platelet-type lipoxygenase 12;
GN   Name=Alox12 {ECO:0000312|RGD:1311159};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   FUNCTION IN APOPTOSIS.
RX   PubMed=15105833; DOI=10.1038/sj.cdd.4401395;
RA   Lebeau A., Terro F., Rostene W., Pelaprat D.;
RT   "Blockade of 12-lipoxygenase expression protects cortical neurons from
RT   apoptosis induced by beta-amyloid peptide.";
RL   Cell Death Differ. 11:875-884(2004).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-246, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY.
RX   PubMed=23382512; DOI=10.1096/fj.12-217414;
RA   Gregus A.M., Dumlao D.S., Wei S.C., Norris P.C., Catella L.C.,
RA   Meyerstein F.G., Buczynski M.W., Steinauer J.J., Fitzsimmons B.L.,
RA   Yaksh T.L., Dennis E.A.;
RT   "Systematic analysis of rat 12/15-lipoxygenase enzymes reveals critical
RT   role for spinal eLOX3 hepoxilin synthase activity in inflammatory
RT   hyperalgesia.";
RL   FASEB J. 27:1939-1949(2013).
CC   -!- FUNCTION: Catalyzes the regio and stereo-specific incorporation of
CC       molecular oxygen into free and esterified polyunsaturated fatty acids
CC       generating lipid hydroperoxides that can be further reduced to the
CC       corresponding hydroxy species (PubMed:23382512). Mainly converts
CC       arachidonate ((5Z,8Z,11Z,14Z)-eicosatetraenoate) to the specific
CC       bioactive lipid (12S)-hydroperoxyeicosatetraenoate/(12S)-HPETE. Through
CC       the production of bioactive lipids like (12S)-HPETE it regulates
CC       different biological processes including platelet activation. It can
CC       also catalyze the epoxidation of double bonds of polyunsaturated fatty
CC       acids such as (14S)-hydroperoxy-docosahexaenoate/(14S)-HPDHA resulting
CC       in the formation of (13S,14S)-epoxy-DHA. Furthermore, it may
CC       participate in the sequential oxidations of DHA
CC       ((4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoate) to generate specialized pro-
CC       resolving mediators (SPMs) like resolvin D5 ((7S,17S)-diHPDHA) and
CC       (7S,14S)-diHPDHA, that actively down-regulate the immune response and
CC       have anti-aggregation properties with platelets (By similarity). An
CC       additional function involves a multistep process by which it transforms
CC       leukotriene A4/LTA4 into the bioactive lipids lipoxin A4/LXA4 and
CC       lipoxin B4/LXB4, both are vasoactive and LXA4 may regulate neutrophil
CC       function via occupancy of specific recognition sites (PubMed:23382512).
CC       Can also peroxidize linoleate ((9Z,12Z)-octadecadienoate) to (13S)-
CC       hydroperoxyoctadecadienoate/ (13S-HPODE) (By similarity). Due to its
CC       role in regulating both the expression of the vascular endothelial
CC       growth factor (VEGF, an angiogenic factor involved in the survival and
CC       metastasis of solid tumors) and the expression of integrin beta-1
CC       (known to affect tumor cell migration and proliferation), it can be
CC       regarded as protumorigenic. Important for cell survival, as it may play
CC       a role not only in proliferation but also in the prevention of
CC       apoptosis in vascular smooth muscle cells (By similarity).
CC       {ECO:0000250|UniProtKB:P18054, ECO:0000250|UniProtKB:P39655,
CC       ECO:0000269|PubMed:23382512}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoate + O2 = (12S)-hydroperoxy-
CC         (5Z,8Z,10E,14Z)-eicosatetraenoate; Xref=Rhea:RHEA:10428,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:32395, ChEBI:CHEBI:57444;
CC         EC=1.13.11.31; Evidence={ECO:0000269|PubMed:23382512};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:10429;
CC         Evidence={ECO:0000250|UniProtKB:P18054};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 H2O + 2 leukotriene A4 + O2 = 2 lipoxin A4;
CC         Xref=Rhea:RHEA:48584, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:57463, ChEBI:CHEBI:67026;
CC         Evidence={ECO:0000269|PubMed:23382512};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 H2O + 2 leukotriene A4 + O2 = 2 lipoxin B4;
CC         Xref=Rhea:RHEA:48588, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:57463, ChEBI:CHEBI:67031;
CC         Evidence={ECO:0000269|PubMed:23382512};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoate + O2 = (15S)-hydroperoxy-
CC         (5Z,8Z,11Z,13E)-eicosatetraenoate; Xref=Rhea:RHEA:16869,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:32395, ChEBI:CHEBI:57446;
CC         EC=1.13.11.33; Evidence={ECO:0000250|UniProtKB:P18054};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16870;
CC         Evidence={ECO:0000250|UniProtKB:P18054};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(14S)-hydroperoxy-(4Z,7Z,10Z,12E,16Z,19Z)-docosahexaenoate =
CC         (13S,14S)-epoxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoate + H2O;
CC         Xref=Rhea:RHEA:53532, ChEBI:CHEBI:15377, ChEBI:CHEBI:78048,
CC         ChEBI:CHEBI:131958; Evidence={ECO:0000250|UniProtKB:P18054};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53533;
CC         Evidence={ECO:0000250|UniProtKB:P18054};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-alanine + O2 = N-(15S)-
CC         hydroperoxy-(5Z,8Z,11Z,13E)-eicosatetraenoyl-alanine;
CC         Xref=Rhea:RHEA:50184, ChEBI:CHEBI:15379, ChEBI:CHEBI:132071,
CC         ChEBI:CHEBI:132077; Evidence={ECO:0000250|UniProtKB:P18054};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:50185;
CC         Evidence={ECO:0000250|UniProtKB:P18054};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-alanine + O2 = N-(12S)-
CC         hydroperoxy-(5Z,8Z,10E,14Z)-eicosatetraenoyl-alanine;
CC         Xref=Rhea:RHEA:50172, ChEBI:CHEBI:15379, ChEBI:CHEBI:132071,
CC         ChEBI:CHEBI:132074; Evidence={ECO:0000250|UniProtKB:P18054};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:50173;
CC         Evidence={ECO:0000250|UniProtKB:P18054};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-gamma-aminobutanoate + O2 =
CC         N-(15S)-hydroperoxy-(5Z,8Z,11Z,13E)-eicosatetraenoyl-gamma-
CC         aminobutanoate; Xref=Rhea:RHEA:50180, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:132072, ChEBI:CHEBI:132078;
CC         Evidence={ECO:0000250|UniProtKB:P18054};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:50181;
CC         Evidence={ECO:0000250|UniProtKB:P18054};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-gamma-aminobutanoate + O2 =
CC         N-(12S)-hydroperoxy-(5Z,8Z,10E,14Z)-eicosatetraenoyl-gamma-
CC         aminobutanoate; Xref=Rhea:RHEA:50176, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:132072, ChEBI:CHEBI:132075;
CC         Evidence={ECO:0000250|UniProtKB:P18054};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:50177;
CC         Evidence={ECO:0000250|UniProtKB:P18054};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-glycine + O2 = N-(15S)-
CC         hydroperoxy-(5Z,8Z,11Z,13E)-eicosatetraenoyl-glycine;
CC         Xref=Rhea:RHEA:50188, ChEBI:CHEBI:15379, ChEBI:CHEBI:59002,
CC         ChEBI:CHEBI:132076; Evidence={ECO:0000250|UniProtKB:P18054};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:50189;
CC         Evidence={ECO:0000250|UniProtKB:P18054};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-glycine + O2 = N-(12S)-
CC         hydroperoxy-(5Z,8Z,10E,14Z)-eicosatetraenoyl-glycine;
CC         Xref=Rhea:RHEA:50168, ChEBI:CHEBI:15379, ChEBI:CHEBI:59002,
CC         ChEBI:CHEBI:132073; Evidence={ECO:0000250|UniProtKB:P18054};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:50169;
CC         Evidence={ECO:0000250|UniProtKB:P18054};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-taurine + O2 = N-(12S)-
CC         hydroperoxy-(5Z,8Z,10E,14Z)-eicosatetraenoyl-taurine;
CC         Xref=Rhea:RHEA:50160, ChEBI:CHEBI:15379, ChEBI:CHEBI:132060,
CC         ChEBI:CHEBI:132061; Evidence={ECO:0000250|UniProtKB:P18054};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:50161;
CC         Evidence={ECO:0000250|UniProtKB:P18054};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-taurine + O2 = N-(15S)-
CC         hydroperoxy-(5Z,8Z,11Z,13E)-eicosatetraenoyl-taurine;
CC         Xref=Rhea:RHEA:50156, ChEBI:CHEBI:15379, ChEBI:CHEBI:132060,
CC         ChEBI:CHEBI:132062; Evidence={ECO:0000250|UniProtKB:P18054};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:50157;
CC         Evidence={ECO:0000250|UniProtKB:P18054};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoate + O2 = (14S)-
CC         hydroperoxy-(4Z,7Z,10Z,12E,16Z,19Z)-docosahexaenoate;
CC         Xref=Rhea:RHEA:41332, ChEBI:CHEBI:15379, ChEBI:CHEBI:77016,
CC         ChEBI:CHEBI:78048; Evidence={ECO:0000250|UniProtKB:P18054};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41333;
CC         Evidence={ECO:0000250|UniProtKB:P18054};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(7S)-hydroperoxy-(4Z,8E,10Z,13Z,16Z,19Z)-docosahexaenoate + O2
CC         = (7S,14S)-dihydroperoxy-(4Z,8E,10Z,12E,16Z,19Z)-docosahexaenoate;
CC         Xref=Rhea:RHEA:64724, ChEBI:CHEBI:15379, ChEBI:CHEBI:156049,
CC         ChEBI:CHEBI:156082; Evidence={ECO:0000250|UniProtKB:P18054};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:64725;
CC         Evidence={ECO:0000250|UniProtKB:P18054};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(7S)-hydroperoxy-(4Z,8E,10Z,13Z,16Z,19Z)-docosahexaenoate + O2
CC         = (7S,17S)-dihydroperoxy-(4Z,8E,10Z,13Z,15E,19Z)-docosahexaenoate;
CC         Xref=Rhea:RHEA:64728, ChEBI:CHEBI:15379, ChEBI:CHEBI:140349,
CC         ChEBI:CHEBI:156049; Evidence={ECO:0000250|UniProtKB:P18054};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:64729;
CC         Evidence={ECO:0000250|UniProtKB:P18054};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoate + O2 = (12S)-
CC         hydroperoxy-(5Z,8Z,10E,14Z,17Z)-eicosapentaenoate;
CC         Xref=Rhea:RHEA:48704, ChEBI:CHEBI:15379, ChEBI:CHEBI:58562,
CC         ChEBI:CHEBI:90772; Evidence={ECO:0000250|UniProtKB:P18054};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48705;
CC         Evidence={ECO:0000250|UniProtKB:P18054};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(8Z,11Z,14Z)-eicosatrienoate + O2 = (12S)-hydroperoxy-
CC         (8Z,10E,14Z)-eicosatrienoate; Xref=Rhea:RHEA:41328,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:71589, ChEBI:CHEBI:78047;
CC         Evidence={ECO:0000250|UniProtKB:P18054};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41329;
CC         Evidence={ECO:0000250|UniProtKB:P18054};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z,12Z)-octadecadienoate + O2 = (13S)-hydroperoxy-(9Z,11E)-
CC         octadecadienoate; Xref=Rhea:RHEA:22780, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:30245, ChEBI:CHEBI:57466;
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:22781;
CC         Evidence={ECO:0000250|UniProtKB:P39655};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z)-eicosatrienoate + O2 = (12S)-hydroperoxy-
CC         (5Z,8Z,10E)-eicosatrienoate; Xref=Rhea:RHEA:41324, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:78043, ChEBI:CHEBI:78046;
CC         Evidence={ECO:0000250|UniProtKB:P39655};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41325;
CC         Evidence={ECO:0000250|UniProtKB:P39655};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(14R,15S)-epoxy-(5Z,8Z,11Z)-eicosatrienoate + O2 = (12S)-
CC         hydroperoxy-(14R,15S)-epoxy-(5Z,8Z,10E)-eicosatrienoate;
CC         Xref=Rhea:RHEA:50276, ChEBI:CHEBI:15379, ChEBI:CHEBI:131965,
CC         ChEBI:CHEBI:132063; Evidence={ECO:0000250|UniProtKB:P39655};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:50277;
CC         Evidence={ECO:0000250|UniProtKB:P39655};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(14S,15R)-epoxy-(5Z,8Z,11Z)-eicosatrienoate + O2 = (12S)-
CC         hydroperoxy-(14S,15R)-epoxy-(5Z,8Z,10E)-eicosatrienoate;
CC         Xref=Rhea:RHEA:50284, ChEBI:CHEBI:15379, ChEBI:CHEBI:131964,
CC         ChEBI:CHEBI:132065; Evidence={ECO:0000250|UniProtKB:P39655};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:50285;
CC         Evidence={ECO:0000250|UniProtKB:P39655};
CC   -!- COFACTOR:
CC       Name=Fe cation; Xref=ChEBI:CHEBI:24875;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00726};
CC       Note=Binds 1 Fe cation per subunit. {ECO:0000255|PROSITE-
CC       ProRule:PRU00726};
CC   -!- ACTIVITY REGULATION: Activated by EGF. Arachidonic acid conversion is
CC       inhibited by (13S,14S)-epoxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoate
CC       (13S,14S-epoxy-DHA) (By similarity). Arachidonate 12-lipoxygenase
CC       activity is decreased when PH decreases from 7.4 to 6 (By similarity).
CC       {ECO:0000250|UniProtKB:P18054, ECO:0000250|UniProtKB:P39655}.
CC   -!- PATHWAY: Lipid metabolism; hydroperoxy eicosatetraenoic acid
CC       biosynthesis. {ECO:0000269|PubMed:23382512}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol. Membrane {ECO:0000250}.
CC       Note=Membrane association is stimulated by EGF. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the lipoxygenase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AABR06064404; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   AlphaFoldDB; F1LQ70; -.
DR   SMR; F1LQ70; -.
DR   STRING; 10116.ENSRNOP00000034009; -.
DR   iPTMnet; F1LQ70; -.
DR   PhosphoSitePlus; F1LQ70; -.
DR   PaxDb; 10116-ENSRNOP00000034009; -.
DR   Ensembl; ENSRNOT00000033098.6; ENSRNOP00000034009.4; ENSRNOG00000027037.6.
DR   UCSC; RGD:1311159; rat.
DR   AGR; RGD:1311159; -.
DR   RGD; 1311159; Alox12.
DR   eggNOG; ENOG502QQSP; Eukaryota.
DR   GeneTree; ENSGT00940000155191; -.
DR   HOGENOM; CLU_004282_3_3_1; -.
DR   InParanoid; F1LQ70; -.
DR   OMA; MEMIMAS; -.
DR   OrthoDB; 999249at2759; -.
DR   TreeFam; TF105320; -.
DR   Reactome; R-RNO-2142696; Synthesis of Hepoxilins (HX) and Trioxilins (TrX).
DR   Reactome; R-RNO-2142700; Synthesis of Lipoxins (LX).
DR   Reactome; R-RNO-2142712; Synthesis of 12-eicosatetraenoic acid derivatives.
DR   Reactome; R-RNO-9018677; Biosynthesis of DHA-derived SPMs.
DR   Reactome; R-RNO-9025106; Biosynthesis of DPAn-6 SPMs.
DR   Reactome; R-RNO-9026290; Biosynthesis of DPAn-3-derived maresins.
DR   UniPathway; UPA00881; -.
DR   PRO; PR:F1LQ70; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000027037; Expressed in esophagus and 18 other cell types or tissues.
DR   ExpressionAtlas; F1LQ70; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISS:UniProtKB.
DR   GO; GO:0042383; C:sarcolemma; IDA:RGD.
DR   GO; GO:0004052; F:arachidonate 12(S)-lipoxygenase activity; ISS:UniProtKB.
DR   GO; GO:0050473; F:arachidonate 15-lipoxygenase activity; ISS:UniProtKB.
DR   GO; GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0016165; F:linoleate 13S-lipoxygenase activity; ISS:UniProtKB.
DR   GO; GO:0019369; P:arachidonic acid metabolic process; IDA:UniProtKB.
DR   GO; GO:0071396; P:cellular response to lipid; IEP:RGD.
DR   GO; GO:0061436; P:establishment of skin barrier; ISS:UniProtKB.
DR   GO; GO:0019395; P:fatty acid oxidation; ISS:UniProtKB.
DR   GO; GO:0051122; P:hepoxilin biosynthetic process; IDA:UniProtKB.
DR   GO; GO:1901751; P:leukotriene A4 metabolic process; ISS:UniProtKB.
DR   GO; GO:0043651; P:linoleic acid metabolic process; ISS:UniProtKB.
DR   GO; GO:0006629; P:lipid metabolic process; ISS:UniProtKB.
DR   GO; GO:0034440; P:lipid oxidation; IBA:GO_Central.
DR   GO; GO:2001303; P:lipoxin A4 biosynthetic process; ISS:UniProtKB.
DR   GO; GO:2001306; P:lipoxin B4 biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0019372; P:lipoxygenase pathway; IDA:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0010656; P:negative regulation of muscle cell apoptotic process; ISS:UniProtKB.
DR   GO; GO:0090331; P:negative regulation of platelet aggregation; ISS:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0043536; P:positive regulation of blood vessel endothelial cell migration; IMP:RGD.
DR   GO; GO:1905956; P:positive regulation of endothelial tube morphogenesis; IMP:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:RGD.
DR   GO; GO:0051901; P:positive regulation of mitochondrial depolarization; IMP:RGD.
DR   GO; GO:1903428; P:positive regulation of reactive oxygen species biosynthetic process; IMP:RGD.
DR   GO; GO:0048661; P:positive regulation of smooth muscle cell proliferation; IMP:RGD.
DR   GO; GO:0033559; P:unsaturated fatty acid metabolic process; ISO:RGD.
DR   Gene3D; 3.10.450.60; -; 1.
DR   Gene3D; 2.60.60.20; PLAT/LH2 domain; 1.
DR   InterPro; IPR000907; LipOase.
DR   InterPro; IPR013819; LipOase_C.
DR   InterPro; IPR036226; LipOase_C_sf.
DR   InterPro; IPR020834; LipOase_CS.
DR   InterPro; IPR020833; LipOase_Fe_BS.
DR   InterPro; IPR001885; LipOase_mml.
DR   InterPro; IPR001024; PLAT/LH2_dom.
DR   InterPro; IPR036392; PLAT/LH2_dom_sf.
DR   PANTHER; PTHR11771; LIPOXYGENASE; 1.
DR   PANTHER; PTHR11771:SF4; POLYUNSATURATED FATTY ACID LIPOXYGENASE ALOX12; 1.
DR   Pfam; PF00305; Lipoxygenase; 1.
DR   Pfam; PF01477; PLAT; 1.
DR   PRINTS; PR00087; LIPOXYGENASE.
DR   PRINTS; PR00467; MAMLPOXGNASE.
DR   SMART; SM00308; LH2; 1.
DR   SUPFAM; SSF49723; Lipase/lipooxygenase domain (PLAT/LH2 domain); 1.
DR   SUPFAM; SSF48484; Lipoxigenase; 1.
DR   PROSITE; PS00711; LIPOXYGENASE_1; 1.
DR   PROSITE; PS00081; LIPOXYGENASE_2; 1.
DR   PROSITE; PS51393; LIPOXYGENASE_3; 1.
DR   PROSITE; PS50095; PLAT; 1.
PE   1: Evidence at protein level;
KW   Cytoplasm; Dioxygenase; Fatty acid metabolism; Hydrolase; Iron;
KW   Lipid metabolism; Membrane; Metal-binding; Oxidoreductase; Phosphoprotein;
KW   Reference proteome.
FT   CHAIN           1..663
FT                   /note="Polyunsaturated fatty acid lipoxygenase ALOX12"
FT                   /id="PRO_0000423852"
FT   DOMAIN          2..114
FT                   /note="PLAT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00152"
FT   DOMAIN          114..663
FT                   /note="Lipoxygenase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00726"
FT   BINDING         360
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00726"
FT   BINDING         365
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00726"
FT   BINDING         540
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00726"
FT   BINDING         544
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00726"
FT   BINDING         663
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00726"
FT   MOD_RES         246
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
SQ   SEQUENCE   663 AA;  75534 MW;  2DC11842CDA025CA CRC64;
     MGRYRVRVVT GAWLFSGSVN LVRLWLVGAH REARLELQLR PARGKEEEFD FDVAEDLGPL
     QFVKLHKEHT VVDDAWFCNL ITVQGPGMSA EAVFPCYRWV QGEGILRLPE GTARLAGDNA
     LDVFQKHREK ELKERQQTYR WATWKQGLPQ TIAADCKDDL PPNMRFHEEK RLDFEWTLKA
     GVLEMGLKRV YTLLRSWNRL EDFDQIFWGQ KSALAEKVHR CWQEDELFGY QFLNGANPML
     LRRSTSLPSR LVLPPGTEEL QAQLEKELKD GCLFEADFIL LDGIPANVIR GEQQYLAAPL
     VMLRMDPSGK LLPMAIQIQP PNPSSPAPTL FLPSDPPLAW LLAKIWVRNS DFQLQELQFH
     LLNTHLVAEV IAVATMRCLP GLHPIFKLLV PHIRYTMEIN TRSRTQLISD GGIFDQVVST
     GGGGHVQLLT RAVAQLTYCS LCPPDDLATR GLLRVPSALY AQDALQLWEV TARYVNGMVH
     LFYQSDDIVR GDPELQAWCR EITEVGLCHA QDRGFPVSFQ SRAQLCHFLT MCVFTCTSQH
     AAINQGQLDW YGWVPNAPCT MRMPPPTSKD DVTMETIMGS LPDVQKSCLQ MTITWHLGRL
     QPDMVPLGHH KEKYFSDPRT KAVLSQFQAD LENLEKEITA RNQQLDLPYE YLKPSRIENS
     ITI
//
